デフォルト表紙
市場調査レポート
商品コード
1474006

更年期障害の世界市場規模、シェア、成長分析、用途別、エンドユーザー別 - 産業予測、2024~2031年

Global Menopause Market Size, Share, Growth Analysis, By Applications(Screening and Diagnosis), By End User(Hospital, Diagnostic Centres) - Industry Forecast 2024-2031

出版日: | 発行: SkyQuest | ページ情報: 英文 219 Pages | 納期: 3~5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
更年期障害の世界市場規模、シェア、成長分析、用途別、エンドユーザー別 - 産業予測、2024~2031年
出版日: 2024年04月28日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 目次
概要

世界の更年期障害市場は、2022年に169億米ドルとなり、予測期間(2024~2031年)のCAGRは5.3%で、2023年の178億米ドルから、2031年までには269億7,000万米ドルに成長する見通しです。

女性の生殖年齢の終わりは、更年期という生物学的に正常なプロセスによって示されます。閉経は月経の終了に代表され、通常45歳から55歳の間に発症します。女性は更年期を通じて、気分の落ち込み、膣の乾燥、ほてり、寝汗など、さまざまな症状が現れます。更年期症状の管理を助けることを目的とした栄養補助食品やその他の商品の市場は拡大しています。これらの商品には、市販薬や処方薬、ハーブサプリメント、ビタミン、ミネラル、その他の栄養補助食品が含まれます。自然でオーガニックな製品への要望、更年期障害に関連する健康障害の有病率の増加、栄養補助食品の健康上の利点に対する意識の高まりはすべて、今後数年間における世界の更年期障害市場の大幅な成長を促進すると思われます。また、世界人口の高齢化、更年期障害に関連する健康リスクに対する意識の高まり、ナチュラル・オーガニック製品への欲求の高まりなど、多くの原因が更年期障害市場を牽引しています。さらに、更年期が近づくにつれ、女性の健康管理への関心が高まっており、これが新たな商品やサービスの創出を後押ししています。

目次

エグゼクティブサマリー

  • 市場概要
  • 運命の輪

調査手法

  • 情報調達
  • 二次・一次情報源
  • 市場規模の推定
  • 市場の前提条件と制限

親市場の分析

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題

主要な市場の考察

  • 技術分析
  • 価格分析
  • サプライチェーン分析
  • バリューチェーン分析
  • 市場のエコシステム
  • IP分析
  • 貿易分析
  • スタートアップ分析
  • 原材料の分析
  • イノベーションマトリクス
  • パイプライン製品の分析
  • マクロ経済指標
  • 主要な投資の分析
  • 主要な成功要因
  • 競合の程度

市場力学と見通し

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • 規制情勢
  • ポーターの分析
  • 将来の混乱についての特別な考察

更年期障害の世界市場:用途別

  • 市場概要
  • スクリーニング・診断

更年期障害の世界市場:エンドユーザー別

  • 市場概要
  • 病院
  • 診断センター
  • 専門クリニック
  • その他

更年期障害の世界市場規模:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • その他欧州地域
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ(MEA)
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ地域

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主要な市場企業が採用した戦略
  • 主要成功戦略
  • 市場における最近の活動
  • 主要企業の市場シェア(2023年)

主要企業プロファイル

  • Pfizer Inc.
  • Novo Nordisk A/S
  • Allergan plc
  • TherapeuticsMD Inc.
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Bayer AG
  • Merck & Co. Inc.
  • Johnson & Johnson
  • GlaxoSmithKline plc
  • Eli Lilly and Company
  • Amgen Inc.
  • AbbVie Inc.
  • Pfizer Inc.
  • Novartis International AG
  • Procter & Gamble Co.
  • Roche Holding AG
  • Sanofi SA
  • Serenity Pharmaceuticals LLC
  • Mithra Pharmaceuticals SA
目次
Product Code: SQMIG35I2115

Global Menopause Market was valued at USD 16.9 Billion in 2022 and is poised to grow from USD 17.8 Billion in 2023 to USD 26.97 Billion by 2031, at a CAGR of 5.3% during the forecast period (2024-2031).

The end of a woman's reproductive years is marked by the normal biological process of menopause. It is typified by the end of menstruation and typically affects people between the ages of 45 and 55. Women may have a variety of symptoms throughout menopause, such as mood swings, vaginal dryness, hot flashes, and night sweats. The market for dietary supplements and other goods intended to assist women in managing menopausal symptoms is expanding. These goods include over-the-counter and prescription drugs, as well as herbal supplements, vitamins, minerals, and other dietary supplements. The desire for natural and organic products, increased prevalence of menopause-related health disorders, and growing awareness of the health advantages of nutritional supplements are all likely to fuel considerable growth in the worldwide menopausal market in the upcoming years. A multitude of causes, such as the aging of the world's population, greater awareness of health risks associated to menopause, and an increasing desire for natural and organic products, are also driving the menopause market. Additionally, as menopause approaches, women are growing increasingly involved in overseeing their health and well-being, which is propelling the creation of new goods and services.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Menopause Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Menopause Market Segmental Analysis

Global Menopause Market is segmented based on treatment, and region. Based on treatment, the market is segmented into dietary supplements, OTC pharma products. Further, OTC pharma products is segmented into hormonal and non-hormonal. Based on region, the global Menopause Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Menopause Market

It is projected that the market would present a number of opportunities due to variables like the growth of non-hormonal therapies, customized medicine, and digital health solutions, as well as the tendency toward natural and herbal cures. Non-hormonal treatments are gaining popularity despite hormone replacement therapy (HRT) being the primary treatment for menopause symptoms for a considerable amount of time. There is an opportunity for pharmaceutical companies and medical practitioners to create effective non-hormonal therapies for symptoms such as mood swings, vaginal dryness, and hot flashes. Menopause affects women differently, so there is no one-size-fits-all method of treating it. The menopausal market may present a significant opportunity for individualized care that considers a woman's unique symptoms, medical background, and way of life. Additionally, wearable technology, telemedicine, and other digital health technologies may benefit women going through menopause. Digital health solutions that help women track their symptoms, get advice and support, and connect with medical specialists are an opportunity.

Restraints in the Global Menopause Market

Notwithstanding the market's enormous growth potential, obstacles include safety worries, a lack of knowledge and stigma, legal restrictions, and a dearth of R&D may prevent it from expanding. Women who utilize hormone replacement treatment (HRT) have been reported to have an increased risk of breast cancer, heart disease, and stroke. This has led to concerns about the safety of HRT and an increase in the demand for non-hormonal therapy. Businesses that specialize in hormone-based therapy would find it challenging to resolve these safety concerns. Many nations still view menopause as a taboo topic, and little is known about it or how it impacts women's health. This could lower demand and make it more difficult for companies to effectively market menopause-related products and services. Furthermore, strict regulatory regulations, particularly for hormone-based therapy, govern the menopausal industry. Companies that create new drugs and therapies must meet stringent safety and efficacy standards before receiving a license to be used. But much remains unknown about menopause and its effects on women's health. The dearth of research and development in the field may make effective treatments and therapies more difficult to come by. These are a handful of the factors that may prevent the market from growing.

Market Trends of the Global Menopause Market

A growing number of women are looking for non-hormonal therapy to manage menopause symptoms because they are concerned about the possible risks associated with hormone-based treatments. Consequently, there is a growing demand for non-hormonal therapies like CBT, herbal remedies, and mindfulness-based programs.

Telemedicine, internet forums, and smartphone apps are becoming more and more popular for treating menopausal symptoms. These choices offer privacy, comfort, and accessibility, which may be particularly appealing to women who are reluctant to seek medical attention related to menopause.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Menopause Market by Applications

  • Market Overview
  • Screening and Diagnosis

Global Menopause Market by End User

  • Market Overview
  • Hospital
  • Diagnostic Centres
  • Specialty Clinics
  • Others.

Global Menopause Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Pfizer Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novo Nordisk A/S
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Allergan plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • TherapeuticsMD Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mylan N.V.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teva Pharmaceutical Industries Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bayer AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck & Co. Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GlaxoSmithKline plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eli Lilly and Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Amgen Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AbbVie Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis International AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Procter & Gamble Co.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Holding AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi SA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Serenity Pharmaceuticals LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mithra Pharmaceuticals SA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments